Lidocaine 4% Maximum Strength 24 Hr
Generic Name: lidocaine 4% maximum strength 24 hr
Brand Names:
Lidocaine Patch
Purpose Temporarily relieves minor pain.
Overview
Purpose Temporarily relieves minor pain.
Uses
Idications and Usage Uses: Temporaily relieves minor pains.
Dosage
Dosage and Administration Directions Adults and children over 12 years: ■ clean and dry affected area ■ carefully remove backing from patch starting at corner ■ apply sticky side of patch to affected area ■ use one patch for up to 24 hours. Discard patch after single use. Children under 12 years of age: consult a physician.
Side Effects
When using this product ■ use only as directed ■ read and follow all directions and warnings on this carton ■ do not allow contact with the eyes ■ do not use at the same time as other topical analgesics ■ do not bandage tightly or apply local heat (such as heating pads) to the area of use ■ do not microwave ■ dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch. Stop use and consult a doctor ■ condition worsens ■ redness is present ■ irritation develops ■ symptoms persist for more than 7 days or clear up and occur again within a few days ■ you experience signs of skin injury, such as pain, swelling or blistering where the product was applied.
Warnings
Warnings For external use only. Do not Use ■ more than one patch on your body at a time ■ on cut, irritated or swollen skin ■ on puncture wounds ■ for more than one week without consulting a doctor ■ if you are allergic to any active or inactive ingredients ■ if pouch is damaged or opened.
Pregnancy
If pregnant or breastfeeding, ask a health professional before use.
Frequently Asked Questions
What is Lidocaine 4% Maximum Strength 24 Hr used for?▼
Idications and Usage Uses: Temporaily relieves minor pains.
What are the side effects of Lidocaine 4% Maximum Strength 24 Hr?▼
When using this product ■ use only as directed ■ read and follow all directions and warnings on this carton ■ do not allow contact with the eyes ■ do not use at the same time as other topical analgesics ■ do not bandage tightly or apply local heat (such as heating pads) to the area of use ■ do not microwave ■ dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch. Stop use and consult a doctor ■ condition worsens ■ redness is present ■ irritation develops ■ symptoms persist for more than 7 days or clear up and occur again within a few days ■ you experience signs of skin injury, such as pain, swelling or blistering where the product was applied.
Can I take Lidocaine 4% Maximum Strength 24 Hr during pregnancy?▼
If pregnant or breastfeeding, ask a health professional before use.
What are the important warnings for Lidocaine 4% Maximum Strength 24 Hr?▼
Warnings For external use only. Do not Use ■ more than one patch on your body at a time ■ on cut, irritated or swollen skin ■ on puncture wounds ■ for more than one week without consulting a doctor ■ if you are allergic to any active or inactive ingredients ■ if pouch is damaged or opened.
Related Medications
Naphazoline Hydrochloride, Polysorbate 80
naphazoline hydrochloride, polysorbate 80
Purpose Naphazoline hydrochloride - Redness reliever Polysorbate 80 - Lubricant
Ado-trastuzumab Emtansine
ado-trastuzumab emtansine
11 DESCRIPTION KADCYLA (ado-trastuzumab emtansine) is a HER2-targeted antibody-drug conjugate (ADC) which contains the humanized anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitory drug DM1 (a maytansine derivative) via the stable thioether linker MCC (4-[N-maleimidomethyl] cyclohexane-1-carboxylate). Emtansine refers to the MCC-DM1 complex.
Fitusiran
fitusiran
Antithrombin-directed RNA Interaction [EPC]
11 DESCRIPTION QFITLIA injection contains fitusiran, an antithrombin-directed double-stranded small interfering ribonucleic acid (siRNA), which is covalently linked to a ligand containing a triantennary N-acetylgalactosamine (GalNAc) moiety. The molecular formula of fitusiran sodium is C 520 H 636 F 21 N 175 Na 43 O 309 P 43 S 6 and the molecular weight is 17,193 Da. Fitusiran drug substance is a white to pale yellow powder and freely soluble in water and phosphate buffered saline.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.